U.S. National Institutes of Health
U.S. National Institutes of Health


IDRankTitleRecruitmentStudy ResultsConditionsInterventionsURL
8856188561The GORE Viabahn Endoprosthesis for the Treatment of Venous Occlusions and StenosesRecruitingNo Results AvailableVenous ThrombosisDevice: Gore Viabahn Heparin Coated Stenthttps://ClinicalTrials.gov/show/NCT01406795
8856288562DNA Analysis in Influencing Response to Rituximab in Samples From Patients With Follicular Lymphoma Treated on ECOG-E4402Not yet recruitingNo Results AvailableLymphomaBiological: rituximab|Genetic: DNA analysis|Genetic: gene expression analysis|Genetic: polymerase chain reaction|Other: laboratory biomarker analysishttps://ClinicalTrials.gov/show/NCT01406782
8856388563Bioimpedance Spectroscopy in Detecting Lower-Extremity Lymphedema in Patients With Stage I, Stage II, Stage III, or Stage IV Vulvar Cancer Undergoing Surgery and LymphadenectomyActive, not recruitingNo Results AvailableLymphedema|Perioperative/Postoperative Complications|Stage IA Vulvar Cancer|Stage IB Vulvar Cancer|Stage II Vulvar Cancer|Stage IIIA Vulvar Cancer|Stage IIIB Vulvar Cancer|Stage IIIC Vulvar Cancer|Stage IVA Vulvar Cancer|Stage IVB Vulvar CancerProcedure: Bioelectric Impedance Analysis|Procedure: Therapeutic Conventional Surgery|Procedure: Lymphadenectomyhttps://ClinicalTrials.gov/show/NCT01406769
8856488564Combination Chemotherapy in Treating Young Patients With Newly Diagnosed High-Risk Acute Lymphoblastic LeukemiaRecruitingNo Results AvailableB-cell Adult Acute Lymphoblastic Leukemia|B-cell Childhood Acute Lymphoblastic Leukemia|Cognitive/Functional Effects|Neurotoxicity|Pain|Philadelphia Chromosome Positive Childhood Precursor Acute Lymphoblastic Leukemia|Therapy-related Toxicity|Untreated AdDrug: clofarabine|Drug: doxorubicin hydrochloride|Drug: hydrocortisone sodium succinate|Radiation: selective external radiation therapy|Drug: cytarabine|Drug: vincristine sulfate|Drug: dexamethasone|Drug: prednisone|Drug: pegaspargase|Drug: methotrexate|Drug: cyclophosphamide|Drug: mercaptopurine tablet|Drug: leucovorin calcium|Drug: thioguanine|Drug: etoposidehttps://ClinicalTrials.gov/show/NCT01406756
8856588565Spine Reference Parameters on EOS ImagingCompletedNo Results AvailableHealthy VolunteersDevice: EOSâ„¢ Acquisitionhttps://ClinicalTrials.gov/show/NCT01406743
8856688566Running Effect on Cardiovascular and Muscular ParametersCompletedNo Results AvailableMales|Untrained|30-50 Years Old|HealthyOther: exercisehttps://ClinicalTrials.gov/show/NCT01406730
8856788567Safety and Efficacy of Exenatide Injection in Subjects With Type 2 Diabetes MellitusRecruitingNo Results AvailableType 2 Diabetes MellitusDrug: Exenatide, Placebohttps://ClinicalTrials.gov/show/NCT01406717
8856888568Effects of Rosiglitazone and Alpha-lipoic Acid on the Patients With Pathologically Proved NASHTerminatedNo Results AvailableNASH (Non-alcoholic Steato-hepatitis)Drug: Rosiglitazone|Drug: alpha-lipoic acid|Drug: Rosiglitazone/alpha-lipoic acidhttps://ClinicalTrials.gov/show/NCT01406704
8856988569Light Flashes to Treat Delayed Sleep Phase Disorder (DSPD)RecruitingNo Results AvailableDelayed Sleep Phase DisorderDevice: Flasheshttps://ClinicalTrials.gov/show/NCT01406691
8857088570Remote Ischemic Preconditioning in Coronary Artery Bypass Grafting With Cold Crystalloid Cardioplegic ArrestRecruitingNo Results AvailableMyocardial InjuryProcedure: RIPC|Procedure: Control|Drug: isoflurane+sufentanil anesthesiahttps://ClinicalTrials.gov/show/NCT01406678
8857188571Skin Autofluorescence (AF) Decision Tree in Detecting Impaired Glucose Tolerance (IGT) or Diabetes Mellitus (DM)CompletedNo Results AvailableDiabetes Mellitus|Impaired Glucose Tolerancehttps://ClinicalTrials.gov/show/NCT01406665
8857288572Optimisation of the Treatment of Infectious BursitisRecruitingNo Results AvailableOlecranon Bursitis|Patellar BursitisProcedure: Two-stage bursectomyhttps://ClinicalTrials.gov/show/NCT01406652
8857388573Ranibizumab for the Management of Recurrent Nosebleeds in Patients With Hereditary Hemorrhagic Telangiectasia (HHT)WithdrawnNo Results AvailableHereditary Hemorrhagic Telangiectasia (HHT)|NosebleedsDrug: Ranibizumabhttps://ClinicalTrials.gov/show/NCT01406639
8857488574Effectiveness of Peer Navigation to Link Released HIV+ Jail Inmates to HIV CareActive, not recruitingNo Results AvailableHIV-infection/AidsBehavioral: Health Navigatorhttps://ClinicalTrials.gov/show/NCT01406626
8857588575Resolution of Effect of Bisphosphonates on Bone in Postmenopausal OsteoporosisEnrolling by invitationNo Results AvailablePostmenopausal OsteoporosisOther: Observationhttps://ClinicalTrials.gov/show/NCT01406613
8857688576Optimal rhCG(Ovidrel®) Dose in Poor Responder During IVF and ICSI CyclesRecruitingNo Results Availablein Vitro Fertilization|Poor ResponderDrug: recombinant hCG (Ovidrel®)https://ClinicalTrials.gov/show/NCT01406600
8857788577Safety and Efficacy of PP4001 for the Treatment of Symptoms Associated With Uncomplicated Urinary Tract InfectionCompletedNo Results AvailableUrinary Tract InfectionDrug: PP4001|Drug: PP4001|Drug: PP4001|Drug: Placebohttps://ClinicalTrials.gov/show/NCT01406587
8857888578Phase I/II Study of OPB-31121 in Patients With Progressive Hepatocellular CarcinomaCompletedHas ResultsHepatocellular CarcinomaDrug: OPB-31121|Drug: OPB-31121 phase2https://ClinicalTrials.gov/show/NCT01406574
8857988579Safety and Efficacy of OMS103HP-S Administered in Joint Irrigation Solution to Subjects Undergoing Arthroscopic MeniscectomyCompletedNo Results AvailableMeniscal TearDrug: OMS103HP-S|Drug: Vehiclehttps://ClinicalTrials.gov/show/NCT01406561
8858088580Safety and Efficacy of Multiple Dosing Regimens of BPS804 in Post Menopausal Women With Low Bone Mineral DensityCompletedNo Results AvailableOsteopenia|OsteoporosisDrug: BPS804|Drug: Placebo|Drug: BPS804|Drug: Placebo|Drug: BPS804|Drug: Placebohttps://ClinicalTrials.gov/show/NCT01406548
8858188581Improvement of Myocardial Blood Flow by PhosphoDiesterase 5 Inhibition in Coronary Artery DiseaseTemporarily not availableNo Results AvailableTherapy Refractory Myocardial Ischemia|Coronary Artery Disease|Unsuitable for Surgical or Percutaneous RevascularisationDrug: Vardenafil|Other: Placebohttps://ClinicalTrials.gov/show/NCT01406535
8858288582Tacrine Effects on Cocaine Self-Administration and PharmacokineticsWithdrawnNo Results AvailableCocaine DependenceDrug: Oral tacrine|Drug: Oral placebohttps://ClinicalTrials.gov/show/NCT01406522
8858388583Safety of A Group A, C Polysaccharide Meningococcal and Type b Haemophilus Influenzal Conjugate Vaccine in ChildrenCompletedNo Results AvailableHealthyBiological: 0.5ml/dose for a person|Biological: 0.5ml/dose for a personhttps://ClinicalTrials.gov/show/NCT01406509
8858488584Best Timing of Insulin Bolus Before Meals of Different ContentsRecruitingNo Results AvailableType 1 Diabetes MellitusDrug: insulinhttps://ClinicalTrials.gov/show/NCT01406496
8858588585Platelet Reactivity in Patients on a Thienopyridine and Awaiting Coronary Artery Bypass GraftingActive, not recruitingNo Results AvailableComplication of Coronary Artery Bypass Graft|Peri-operative Hemorrhage or Hematoma|Post Operative BleedingOther: Platelet reactivity assessmenthttps://ClinicalTrials.gov/show/NCT01406483
8858688586Phase 3 Study of Immune Globulin Intravenous (Human)IVIG-SNâ„¢ in Subjects With Primary ImmunodeficiencyCompletedNo Results AvailableImmunologic Deficiency SyndromeDrug: Immune Globulin Intravenous (Human) 5% Liquid, IVIG-SNâ„¢https://ClinicalTrials.gov/show/NCT01406470
8858788587Monitoring of Delayed Ischemia After Subarachnoid HemorrhageRecruitingNo Results AvailableSubarachnoid Hemorrhagehttps://ClinicalTrials.gov/show/NCT01406457
8858888588IGF-1 and Bone Loss in Women With Anorexia NervosaRecruitingNo Results AvailableAnorexia Nervosa|Osteopenia|OsteoporosisDrug: rhIGF-1|Drug: Risedronate|Drug: Placebohttps://ClinicalTrials.gov/show/NCT01406444
8858988589Pharmacokinetic Study of Livalo® Fixed Combination Drug in Healthy SubjectsCompletedNo Results AvailableHyperlipidemia|HypertensionDrug: Pitavastatin, Valsartan|Drug: Livalo® fixed combination drughttps://ClinicalTrials.gov/show/NCT01406431
8859088590Assessment of CR6261, a Monoclonal Antibody Against the Influenza A VirusCompletedNo Results AvailableInfluenzaBiological: CR6261 2 mg/kg|Biological: CR6261 5 mg/kg|Biological: CR6261 15 mg/kg|Biological: CR6261 30 mg/kg|Biological: CR6261 50 mg/kg|Biological: Placebohttps://ClinicalTrials.gov/show/NCT01406418

* Görseller ve İçerik tekif hakkına sahip olabilir